Arbutus Biopharma Corp (NASDAQ: ABUS) Receives A Nod To Investigate New Drug, Rosen Law Firm Issues Loss Alert, Halper Sadeh LLP Initiates Investigating Companies

Arbutus Biopharma Corp (NASDAQ: ABUS) is back in the news. First, the company announced that it had received a go-ahead from the U.S. Food and Drug Administration to investigate New Drug (IND) application for AB-729 in a Phase 2a clinical trial. The Phase 2a proof-of-concept clinical trial will evaluate the safety and efficacy of AB-729 in combination with ongoing nucleos(t)ide analog (NA) therapy and short courses of Peg-IFNα-2a in subjects with CHB.

William Collier, President and Chief Executive Officer of Arbutus, stated, “The acceptance of our IND application is an important step forward for AB-729 and supports our objective to establish its value as a cornerstone therapy for patients with CHB. We look forward to the initiation of this proof-of-concept Phase 2a clinical trial in this quarter.”

Washington Prime Group Inc (NYSE: WPG) investors sent a reminder by Rosen Law Firm about the lead plaintiff deadline. 

Washington Prime Group Inc (NYSE: WPG) stakeholders were reminded of the lead plaintiff deadline by Rosen Law Firm. The law firm stated that investors who purchased securities during the Class Period could be eligible for compensation. The statement added that a class action lawsuit has already been filed. The law firm reminded investors that those who wish to serve as lead plaintiff must move the Court no later than July 23, 2021. The Rosen Law Firm works on behalf of investors throughout the globe. The law firm concentrates its practice in securities class actions and shareholder derivative litigation.

US Concrete Inc (NASDAQ: USCR) and three other companies under legal investigation

US Concrete Inc (NASDAQ: USCR), QTS Realty Trust Inc Class A (NYSE: QTS), Contango Oil & Gas Co (Texas) (NYSEAMERICAN: MCF), and Advaxis, Inc. (NASDAQ: ADXS) are under the legal investigation of Halper Sadeh LLP law firm. The corporate houses are allegedly accused of possible violations of the federal securities laws and/or breaches of fiduciary duties. Shareholders of the stated companies can contact the law firm and discuss their legal rights and options. Halper Sadeh LLP law firm works on behalf of investors who are victims of securities fraud and corporate misconduct.  

Leave a Comment

Your email address will not be published.